The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Wataru Ichikawa

Department of Clinical Oncology and Medical Oncology

International Medical Center

Saitama Medical University

1397-1 Yamane

Japan

[email]@saitama-med.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Clinical Oncology and Medical Oncology, International Medical Center, Saitama Medical University, 1397-1 Yamane, Japan. 2008
  • Second Department of Surgery, Saitama Medical School, Saitama 350-04925, Japan. 2003 - 2006
  • Department of General and Digestive Surgery, Saitama Medical School, 38, Moro-Hongo, Moroyama, Japan. 2006

References

  1. Challenges in predicting the clinical outcome in S-1-based chemotherapy for gastric cancer patients. Ichikawa, W., Sasaki, Y. Int. J. Clin. Oncol. (2008) [Pubmed]
  2. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin. Ichikawa, W., Ooyama, A., Toda, E., Sugimoto, Y., Oka, T., Takahashi, T., Shimizu, M., Sasaki, Y., Hirayama, R. Cancer Chemother. Pharmacol. (2006) [Pubmed]
  3. Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1. Ichikawa, W., Takahashi, T., Suto, K., Shirota, Y., Nihei, Z., Shimizu, M., Sasaki, Y., Hirayama, R. Int. J. Cancer (2006) [Pubmed]
  4. Orotate phosphoribosyltransferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimen. Ichikawa, W., Takahashi, T., Suto, K., Sasaki, Y., Hirayama, R. Clin. Cancer Res. (2006) [Pubmed]
  5. Correlation between tumor response to first-line chemotherapy and prognosis in advanced gastric cancer patients. Ichikawa, W., Sasaki, Y. Ann. Oncol. (2006) [Pubmed]
  6. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer. Ichikawa, W., Takahashi, T., Suto, K., Nihei, Z., Shirota, Y., Shimizu, M., Sasaki, Y., Hirayama, R. Int. J. Cancer (2004) [Pubmed]
  7. Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. Ichikawa, W., Takahashi, T., Suto, K., Yamashita, T., Nihei, Z., Shirota, Y., Shimizu, M., Sasaki, Y., Hirayama, R. Br. J. Cancer (2004) [Pubmed]
  8. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Ichikawa, W., Uetake, H., Shirota, Y., Yamada, H., Nishi, N., Nihei, Z., Sugihara, K., Hirayama, R. Clin. Cancer Res. (2003) [Pubmed]
  9. Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Ichikawa, W., Uetake, H., Shirota, Y., Yamada, H., Takahashi, T., Nihei, Z., Sugihara, K., Sasaki, Y., Hirayama, R. Br. J. Cancer (2003) [Pubmed]
 
WikiGenes - Universities